Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Nausea and Vomiting Secondary to FOLFIRINOX Chemotherapy in Gastrointestinal Cancer Patients

NCT01504711 is registered in ClinicalTrials.gov with Philip Philip as lead sponsor.

NCT NCT01504711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01504711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Nausea and Vomiting Secondary to FOLFIRINOX Chemotherapy in Gastrointestinal Cancer Patients
Lead sponsor
Philip Philip
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2012
Completion date
September 3, 2020
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal cancer, nausea post chemotherapy